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Introduction 
Reduced or altered taste and smell function may occur as a side-effect of cancer 
therapy. This can lead to altered nutrient and energy intake. Some studies have 
suggested that taste and smell dysfunction can persist many years after treatment 
completion but this has not been previously assessed in survivors of childhood cancer.  
The aim of this study is to determine if taste and smell dysfunction is present in 
childhood cancer survivors (CCS).  Food preference and Quality of Life was also 
assessed. 
Methods 
Fifty-one child cancer survivors (mean age: 19.69 ±7.09 years), more than five years 
since treatment completion, (mean: 12.4 years) were recruited from the long term 
follow-up clinics at two Sydney-based children’s hospitals. Taste function was assessed 
using a 25 sample taste identification test comprising five concentrations each of sweet, 
salty, sour and bitter tastes and water. Smell function was assessed by determining the 
ability of participants to identify 16 common odorants. The participants’ Quality of Life 
was assessed using the Functional Assessment of Anorexia Cachexia scale and food 
preferences were assessed using a 94-item food liking tool. 
Results 
Taste dysfunction was found in 27.5% of participants (n=14), and smell dysfunction in 
3.9% (n=2) of participants. The prevalence of taste dysfunction was higher than that 
seen in the non-cancer population. The child cancer survivors’ appeared to  “like” the 
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less healthy food groups such as flavoured beverages, takeaway and snacks over 
healthier food groups such as vegetables and salad. No correlation was found between 
those with a taste dysfunction and their food “likes” 
Conclusion 
A high level of taste dysfunction was found in CCS though there did not appear to be an 
issue with smell dysfunction. Further work is also needed to assess whether a taste 
dysfunction do play a role in the dietary habits of CCS. 
 
Introduction 
 
One potential side-effect of cancer therapy is reduced or altered taste and smell function 
[1]. Both taste and smell receptor cells rapidly turn over and are produced from dividing 
basal cells [2-3]. The division mechanism is sensitive to the effects of chemotherapy 
and/or radiotherapy [4]. The senses of taste and smell are integral in motivating a 
person’s food preferences [5-6] and both child and adult cancer patients commonly 
attribute difficulties maintaining food intake to the altered taste developed during 
treatment [1, 7-8]. Altered taste in cancer patients has also been associated with 
decreased energy and nutrient intake [9], potentially leading to nutrient deficiencies 
[10]. 
 
Although the taste and smell receptor cells are replaced regularly over several weeks 
and longer, cancer therapy can potentially lead to long term taste and smell receptor 
damage. This occurs due to an alteration in the structure of the receptors or a decrease 
in the number of normal receptor cells [10]. Long-term taste and smell dysfunction has 
been documented in the adult oncology population [11-12]. Patients who have received 
radiation therapy for head and neck cancer and those who have undergone a 
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Hematopoietic Stem Cell Transplant (HSCT) demonstrate taste dysfunction, after their 
cancer treatment, up to seven and three years respectively. [11, 13]  
 
Survivors of childhood cancer have been shown to have poor dietary habits [14-16] and 
preferences for high fat foods [17].  In the general population, those with a documented 
taste or smell dysfunction can alter their food intake, either by compensating for the lack 
of flavour in foods with an increase in intake, or  decreasing their intake due to a lack of 
enjoyment of the food [18, 9]. Taste dysfunction has also been associated with obesity 
in both adults and children [19-20] in the general population. The taste and smell 
function of childhood cancer survivors  (CCS) has not been previously assessed. If CCS 
are found to have a taste or smell dysfunction this may be one factor  influencing their 
food preferences and dietary intake. The aim of this study was to assess smell and taste 
function in this population and to determine whether this influences food preferences 
which could in turn influence their dietary intake. To this end, it was hypothesised that 
the CCS level of taste and smell functioning would be related to food liking scores. 
 
Methods 
Participants 
Participants were CCS who were at least 5 years since cancer treatment completion and 
who attended the long-term follow-up clinics for a their yearly review, at Sydney 
Children’s Hospital, Randwick and the Children’s Hospital Westmead, Australia, between 
July and September 2011. Participants were excluded from participation if they were 
under the age of 12 years, did not speak English or were pregnant. Participants were 
also excluded if they had known problems with swallowing as the testing required 
participants to swallow a small amount of the tasting solutions. The study protocol was 
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approved by The Royal Alexandra Hospital for Children Ethics Committee (Approval No. 
11/CHW/24) and informed consent was obtained from all participants 
 
Demographics 
Demographic information (Table 1) collected from the medical records of participants 
included, age, sex, cancer diagnosis, type of treatment received, time since treatment 
completion and current medications. 
 
Taste Identification 
Taste function was assessed by the ability to identify four different tastes – sweet, sour, 
salty and bitter across five different concentrations, and five samples of water. Each 
participant was familiarised with the test procedure by sipping a few millilitres of a 
moderate strength solution Each child was familiarized with the test by being asked to 
sip a solution (2–3 ml of a single sample) that was moderately sweet (sucrose, 0.36 M; 
Sigma, Sydney, Australia), salty (sodium chloride, 0.18 M; BDH, Sydney, Australia), sour 
(citric acid, 0.009 M; BDH) and bitter (quinine hydrochloride, 0.0001 M; Aldrich, Sydney, 
Australia), respectively, and water (Nobles Ultra Pure Water, Sydney, Australia). Test 
tastant concentrations were prepared by dissolving analytical grade sucrose (0.05, 0.08, 
0.12, 0.20, 0.32 M, Sigma, Sydney, Australia) citric acid (0.0038, 0.0062, 0.0100, 
0.0159, 0.0256M BDH, Sydney, Australia) , sodium chloride (0.07, 0.11, 0.18, 0.28, 
0.46 BDH) and quinine hydrochloride (0.00009, 0.00016, 0.00026, 0.00041, 0.00065M, 
Aldrich, Sydney, Australia) in purified drinking water (Nobles Ultra Pure Water, Sydney).  
For each of the 25 samples, participants were presented with a small amount of tastant 
solution and then asked to select one of three labelled photographs which best described 
the taste they had sampled. The photographs were a pictorial representation of the 
tastant. The photographs also contained the name of the three tastants represented e.g. 
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sweet, sour, salty, bitter or water. The assessor read out all three names to the 
participant [21] before they made their choice. The 25 tastants were presented to each 
participant in a random order with a 20-30 second break between the assessment of 
each tastant. Participants were advised to rinse their mouth with pure water between 
each sample.  
 
For each tastant, participants who identified less than four out of the five concentrations 
for each individual tastant were considered to have impairment in their ability to detect 
that taste [21]. This criteria was established from normative data for children (n=232)  
and adults (n= 56) older than five years, using the same test procedure [21]. The same 
criteria for taste impairment has been used with participants with cystic fibrosis [22], 
chronic kidney disease [23] and healthy school children [24]. 
 
Smell Identification 
Smell function was assessed by determining the ability of participants to identify 16 
common odorants including Dettol™ (a common antiseptic product based on 
chloroxylenol), sour, baby powder, fishy, grassy, paint, flowers, strawberry, cheesy, 
petrol, spicy, onion, Vicks VapoRub™ (odour of mentholated topical cream), minty, 
orange and chocolate. The 16 odorants were diluted to a total volume of 20ml with 
odourless dipropylene glycol (Fluka 99% pure) and placed in individual opaque squeeze 
bottles which each participant was shown how to squeeze and sniff from the bottle [21]. 
The participants were then presented with three labelled photographs and asked to pick 
the one most representative of the smell they had just been presented. The photographs 
were a pictorial representation of the odorant combined with the name of the odorant. 
The test was developed not only for adults but for use with children from five years of 
age [21]. It was developed with children five to nine years old (n=232) and adults 
(n=56).  Early data indicated that children from nine years of age performed similarly to 
adults [25]. In addition, it has been shown to have a test-retest reliability of 0.98 [24] 
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indicating a high level of reliability. A score of less than 13 out of a possible 16 (e.g. 
more than four smells incorrectly identified) was defined as an olfactory impairment 
[21].  
 
Quality of Life (QoL) 
The Functional Assessment of Anorexia/Cachexia Treatment QoL scale (FAACT) was used 
for participants greater than 18 years of age and the Pediatric Functional Assessment of 
Anorexia Cachexia (Peds-FAACT) used for participants less than 18 years of age. These 
tools are validated in this population to measure health related quality of life [26-27]  
and contain an additional items section on issues relating to anorexia/cachexia. This tool 
was used as a subjective measure of the severity of food-related symptoms such as 
taste change and poor appetite. 
 
Food Liking 
A 94-item food liking questionnaire was used to elicit participant’s food preferences [28-
29]. The questionnaire required participants to rate their attitudes towards a range of 
common foods on a scale of 0 to 5, with 0 = not having tried a food, 1 = hating a food, 
up to 5 = loving the food. The responses were then sorted according to 10 food groups; 
meat/fish, vegetarian foods other than vegetables, bakery goods, breakfast foods, 
convenience foods/takeaways, dairy foods, fruit, snacks, green vegetables/salad and 
other vegetables. The mean liking scores for each of the 10 categories were calculated. 
The higher the mean score, the more likely the food  group was “liked”.  This data was 
then analysed to illustrate trends in participant’s food likes. 
 
Statistical Analysis 
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Statistical analyses were performed using IBM SPSS version 19 (IBM Corp., Armonk, 
New York). Previous research in clinical and non-clinical populations using the same 
taste and smell tests utilised here indicate that the majority of people score towards the 
high-functioning end of the scale on both of these tests [24, 30, 22]. Since the 
underlying distribution of these smell and taste tests are non-normal, and the 
comparisons between treatment groups involved small and uneven group sizes, non-
parametric statistics were considered the most appropriate method of analyses for the 
current data [31]. Differences and associations were considered significant at p<.05 (2-
tailed). Bonferroni corrections were applied to alpha for all subsequent post-hoc tests to 
reduce the chance of type I error [31]. The specific analyses used to examine each of 
the variables are described in the respective results sections. Where Bonferroni 
corrections have been applied, the relevant adjusted alpha level is indicated alongside 
the reported results and significance values. 
 
Results 
Demographics 
Fifty-five childhood cancer survivors were approached to participate in the study of which 
51 (93%) were recruited. The mean age of the participants was 19.69 (±7.09) years and 
a mean of 12.4 (±6.87) years had passed since completion of their treatment (Table 1). 
Taste 
Taste dysfunction was found in 14 of the 51 participants (27.5%). Of those with a taste 
dysfunction, five (9.8%), eight (15.7%), four (7.8%) and six (11.8%) had a sweet, sour, 
salty or bitter dysfunction, respectively. Seven participants had a dysfunction involving 
one tastant only, five had a dysfunction involving two tastants and two had a dysfunction 
involving three tastants . No patient had a dysfunction involving all four tastants.  A 
Friedman’s ANOVA test indicated the total scores for sweet (4.47 ± 0.67), sour (4.45 ± 
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0.86), salty (4.61 ± 0.70), bitter (4.47 ± 0.92) and water (4.45 ± 1.12) were not 
significantly different (p=0.490).  
 
A series of Spearman’s correlation tests found no significant relationship between taste 
scores and the age at diagnosis (rho= -0.078; p= 0.585) or years since treatment 
completion (rho= -0.101; p=0.481). When these variables were correlated with 
individual tastant scores there was a significant negative correlation between age and 
bitter score (rho= -.357; p = 0.01) suggesting that as age increased participants were 
less able to identify a bitter taste. No other significant results were found. When the 
participants were separated into three treatment types (chemotherapy (n=27), 
chemotherapy + radiotherapy (n=17), HSCT (n=7)) a Kruskall-Wallis test indicated that 
there were no significant differences in total taste scores between the treatment types. 
It should be noted that the power to find differences between treatment types was 
limited by small group sizes, for analyses between the three treatment types the power 
ranged between 0.18 and 0.34. 
 
Smell 
Of the 51 participants, six participants (11.8%) were identified as having some degree of 
a smell dysfunction. Two (3.9%) identified only nine of the 16 odors and were classified 
as hyposmic (i.e. significant loss of smell function). Four of the participants were slightly 
hyposmic with scores of 11 and 12 out of 16 respectively. Sour and flower odorants were 
the least identified odorants while Vicks VapoRub™, minty and paint were identified by 
all the participants (Figure 1). 
 
A series of Spearman’s correlation tests found no significant relationship between smell 
scores and age of participants (rho=-0.223; p=0.116), time since treatment completion 
(rho=-0.178; p=0.211), or age at diagnosis (rho= -0.165; p=0.248). A comparison of 
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the smell scores between the three treatment groups (chemotherapy (n=27), 
chemotherapy + radiotherapy (n=17), HSCT (n=7)) using a Kruskall-Wallis test found a 
significant difference (p=0.013). Post-hoc Mann-Whitney tests indicated the odour 
identification scores for the chemotherapy-only group were significantly higher than for 
the HSCT group [p=0.004;Bonferroni adjusted α= 0.0167]. Again, it should be noted 
that the small group sizes limited power to find significant differences between treatment 
types (power ranged 0.18 to 0.34). Of the six participants with hyposmia, four of these 
received a HSCT transplant of whom two received total body irradiation (TBI) as part of 
their treatment. No other significant differences were found when comparing the 
treatment groups.  
 
Food Liking 
The final mean score for each food category was out of five with the higher the score, 
the more likely the food was “liked” (Figure 2). The data showed that the most “liked” 
foods were non-dairy liquids (4.0), followed by takeaway (3.84) and snacks (3.8). The 
least “liked” food groups were the salads and greens (3) followed by breakfast cereal 
(3.03), vegetarian food (3.14) and then vegetables (3.3).  
 
Spearman’s correlations indicated a significant negative correlation between smell score 
and liking for snacks (rho=-0.294, p =0.036). Thus, as the smell score decreased the 
liking for snacks increased. In contrast, a significant positive correlation was found 
between smell score and salad/greens, (rho=0.404, p=0.003), suggesting that as the 
smell score increased liking of salad/greens also increased. Mann-Whitney tests 
comparing the food liking scores between those with and without a smell dysfunction 
found significantly higher mean food liking scores (possible score out of five) for those 
without a smell dysfunction for dairy foods (2.90 vs. 3.56; p=0.027), fruit (2.14 vs. 
3.92; p= 0.001) and salad/greens (1.61 vs. 3.19; p= 0.0001). No significant differences 
or correlations were found between the food groupings and the  taste scores. The 
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treatment group numbers were small, therefore results should be interpreted with 
caution. The results of this study indicate that the differences in food liking for those with 
and without a smell dysfunction along with the above significant correlations provide 
partial support for the hypothesis that smell function is related to CCS food liking. 
 
Quality of Life 
Results from the additional concerns section of the QoL tool indicated that the 
participants had no significant food related concerns (Table 2). For example, the mean 
score for the section on “food tasting bad” was rated low. Correlation tests showed there 
were no significant relationships between smell and taste function (total scores) and any 
food-related QoL measure.  Mann-Whitney tests comparing the individual QoL domains 
between those with a taste dysfunction and those who did not, found a significantly 
higher QoL score for those with a taste dysfunction in response to “My general health is 
improving” (3.46 vs. 2.29 p=0.016). There were no QoL associations found when 
comparing those with and without a smell dysfunction. 
 
 
Discussion 
The results of this study in CCS demonstrate that 27.5% (n=14) had some degree of 
taste dysfunction and 4% (n=2) had a significant smell dysfunction. There was an 
absence of relationships between taste, food liking and QoL and the modest relationship 
between smell dysfunction and liking for healthy foods.  
 
The prevalence of a taste dysfunction in adult oncology patients during chemotherapy 
has been reported to be as high as 40% [9] using objective measures or 86% using 
subjective measures such as self-report [18]. In the paediatric oncology population, 
prevalence rates of a taste dysfunction do not exist though it has been reported to be an 
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issue during cancer therapy [32, 7]. A taste dysfunction during the more intensive 
pediatric HSCT have been reported to be around 40% [30].  
 
The findings in this study show a high prevalence rate of taste dysfunction in survivors of 
childhood cancer. Some studies have suggested that taste dysfunction continues well 
after treatment completion [11-12] but this is the first study to assess this in a cohort of 
survivors of childhood cancer.  There are wide variations in the prevalence rates of taste 
dysfunction in the general population. Taste disorders have been reported to range from 
0.85% [34] to 20% [35]. The prevalence rates have been found using a wide variety of 
methodology for taste assessment and make it difficult to adequately compare findings. 
A relevant comparison of our prevalence rate of a taste dysfunction of 27% (n=14) in 
the CCS, is with a group of  healthy, nine to 12 year old Australian children (n=432).  
The group of healthy Australian children exhibited a taste loss prevalence of 10% using 
the same taste test as used with the CCS and with the same criterion for defining taste 
loss [25].  
 
Accordingly, the prevalence of taste loss of CCS is higher than the general population 
and is a potential undesirable outcome as a result of the cancer itself or the treatment 
received. The mechanism(s) for taste loss in the present group of cancer patients is 
unknown. Possible explanations include a reduction in the number of taste and smell 
receptors as a result of the cytotoxic effects of treatment; changes in the rate of 
turnover of receptor cells, changes induced in the structure of receptors affecting the 
delivery of taste and smell molecules to taste and smell receptors, or abnormalities in 
the reestablishment of synaptic connections at the end of cancer treatment [6]. 
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The incidence of smell dysfunction in the present study (3.9%; (n=2)) is slightly higher 
than the a 1.9% found using the present 16-odour identification test with a cohort of 
nine to 12 year old Australian children [25]. Although the numbers are small in this 
study there is the suggestion that the smell dysfunction can be influenced by the type of 
treatment received. Four of the six participants who had a smell dysfunction underwent 
a HSCT of whom two received TBI. This may reflect greater and more lasting damage to 
the olfactory system with the more intensive treatment.  Further work investigating taste 
function may be warranted with this group.   
 
The results from this study indicate childhood cancer survivors appear to  
“like” less healthy food groups such as flavoured beverages, takeaway and snacks over 
healthier food groups such as vegetables and salad. These results are consistent with 
previous research findings with childhood cancer survivors who displayed unhealthy 
eating habits, such as a poor vegetable intake and a high fat and sugar intake [16, 14-
15]. Despite these findings there did not appear to be any association with food likes and 
taste function. In partial support of the hypothesis, there did appear to be some 
association with a smell dysfunction and a reduced liking of dairy, fruit and salad/greens.  
Further work is needed to confirm whether taste or smell dysfunction is affecting CCS’s 
food choices. 
 
Whilst taste and smell function does not appear to have a key role in the long term food 
likes of CCS, research suggests that treatment for malignancies may still have an 
influence on food preferences through the development of food aversions. It has been 
reported that the likelihood of an individual selecting a food for a second time is related 
to their prior experiences [33]. This may be relevant to the development of food 
aversions in the setting of cancer treatment as taste and smell alterations during the 
period of the disease and subsequent treatments coupled with symptoms of nausea and 
vomiting may have resulted in negative experiences during feeding [34, 10].  The effect 
  
15 
 
of food aversions may be even more pronounced in those receiving treatment for cancer 
at very young ages as food preferences are thought to be largely established through 
experiences with food in the first 3 years of life [35]. 
 
The results from the QoL tool indicate that this cohort have an acceptable QoL as 
demonstrated by the ratings of participants which corresponded to low levels of concern 
about weight and appetite.  Participants did not report that “food tasted bad” despite 
27.5% (n=14) of this cohort displaying some form of taste dysfunction. Furthermore, 
there was no association found between QoL scores and taste and smell scores. Previous 
studies suggest that QoL is influenced by perceived level of olfactory dysfunction rather 
than actual degree of dysfunction [36-37].  It may be that a similar phenomenon occurs 
with taste dysfunction.  
 
 
Conclusion 
It is concluded that taste dysfunction occurs in pediatric long term cancer survivors 
although no relationships were found between taste function and food likes, and taste 
function and Qol. It does not appear that a smell dysfunction were as prevalent though 
the incidence may be slightly higher than the general population.   It is known that CCS  
have undesirable food habits therefore larger prospective longitudinal studies are needed 
to further understand the reasons for these poor dietary habits. Further work is also 
needed to assess whether taste dysfunction plays a role in these dietary habits. 
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Figure Legends 
 
Figure 1. Percentage of participants who correctly identified each odorant 
 
Figure 2. Mean liking scores for each food category (0 = not having tried a food, 1 = 
hating a food, up to 5 = loving the food). 
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Table 1. Demographics of childhood cancer survivors 
 
Characteristic  
Sex (male:female) 24:27  
Age at assessment,  
              Mean (SD)(range): Years 
 
19.69 (7.09)(12-40) 
Age at diagnosis,  
              Mean (SD)(range): Years 
 
5.27 (4.05)(0-17) 
Time since treatment completion 
              Mean (SD)(range): Years 
 
12.40 (6.87)(5-38) 
Cancer diagnosis (n)  
ALL* 18  
AML** 1  
Neuroblastoma 4  
Wilms tumour 4  
Rhabdomyosarcma 3  
Lymphoma 4  
Medulloblastoma 
Ewing’s Sarcoma 
Osteosarcoma 
Other 
2  
2 
3 
10 
Treatment (n) 
               Chemotherapy 
               Chemotherapy + Radiotherapy 
                    Cranial Radiotherapy 
 
27  
17 
6 
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                    Abdominal Radiotherapy 
                    Head and Neck Radiotherapy 
                    Other sites 
                    HCST# 
                    Total Body Irradiation 
                                  
2 
1 
8 
7 
4 
  
* ALL: Acute Lymphoblastic Leukemia ** AML: Acute Myeloid Leukemia # HSCT: Haematopoietic stem cell 
transplant (HSCT) 
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Table 2. Mean score for questions in additional concerns section of the Functional 
Assessment of Anorexia/Cachexia Treatment QoL scale FAACT (Possible values 0 = Not 
at all; 1 = A little bit; 2 = somewhat; 3 = Quite a bit; 4 = very much) 
  
FAACT Question Mean ± SD Range 
I have a good appetite 2.80 ± 1.34 0-4 
The amount I eat is sufficient to meet my 
needs 
2.92 ± 1.13 0-4 
I am worried about my weight 1.33 ± 1.43 0-4 
Most food tastes unpleasant to me 0.35 ± 0.86 0-3 
I am concerned about how thin I look 0.37 ± 0.78 0-3 
My interest in food drops as soon as I try to 
eat 
0.29 ± 0.74 0-4 
I have difficulty eating rich or “heavy” foods 0.35 ± 0.93 0-4 
My family or friends are pressuring me to 
eat 
0.33 ± 0.83 0-4 
I have been vomiting 0.12 ± 0.39 0-2 
When I eat, I seem to get full quickly 0.80 ± 1.32 0-4 
I have pain in my stomach area 0.29 ± 0.65 0-2 
My general health is improving 2.80 ± 1.39 0-4 
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Highlights 
 
• Reduced or altered taste and smell function is a side-effect of cancer therapy  
• This is the first study to assess the taste and smell function in survivors of childhood cancer 
• Higher than expected levels of taste dysfunction was found in this population 
• Smell dysfunction appears to influence food likes for dairy, fruit and salad/greens. 
 
 
 
